Get started
Author

C. Thiébaut

Observed names: Charlène Thiebaut, Thiebaut, Charlène, Thiébaut, Charlène
Observed institutions: Lyon 1 Université, Centre National de la Recherche Scientifique, Inserm, Université de Lyon, CRAN, Centre de Recherche en Cancérologie de Lyon, Université de Lorraine
ORCID: 0000-0002-4338-2753
Observed ORCID: 0000-0002-4338-2753
OpenAlex ID: A5077986907
Structure, Activity, and Function of PRMT1
2021 · Charlène Thiebaut, Louisane Eve, et al. · Life · 118
PDF
Non-genomic signaling of steroid receptors in cancer
2021 · Charlène Thiebaut, Virginie Vlaeminck-Guillem, et al. · Molecular and Cellular Endocrinology · 47
PDF
The Role of ERα36 in Development and Tumor Malignancy
2020 · Charlène Thiebaut, Henri-Philippe Konan, et al. · International Journal of Molecular Sciences · 44
PDF
Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer Cells
2019 · Charlène Thiebaut, Amand Chesnel, et al. · International Journal of Molecular Sciences · 21
PDF
Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression
2017 · Charlène Thiebaut, Clémence Chamard-Jovenin, et al. · PLoS ONE · 20
PDF
Low-Dose Alkylphenol Exposure Promotes Mammary Epithelium Alterations and Transgenerational Developmental Defects, But Does Not Enhance Tumorigenic Behavior of Breast Cancer Cells
2017 · Clémence Chamard-Jovenin, Charlène Thiebaut, et al. · Frontiers in Endocrinology · 15
PDF
Targeting PRMTs Creates Vulnerability of DNA Double‐Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC
2026 · Charlène Thiebaut, Sébastien Martinez, et al. · Cancer Science · 1
A statistical methodology to select covariates in high-dimensional data under dependence. Application to the classification of genetic profiles in oncology
2020 · B. Bastien, T. Boukhobza, et al. · Journal of Applied Statistics · 1
Targeting PRMTs creates vulnerability of double stand break repair pathways, and potentiates chemotherapy efficacy in TNBC
2024 · Martinez, Sebastien, Thiebaut, Charlène, et al. · HAL
Inhibition of protein arginine méthyltransferases: a promising strategy to reverse radio and chemoresistance induced by a dysregulation of the DNA damage response in TNBC
2022 · Thiebaut, Charlène, Eve, Louisane, et al. · HAL
Abstract 649: Targeting progesterone receptor (PR) with the antiprogestin onapristone in patient-derived xenograft (PDX) models of estrogen receptor positive (ER+), PR positive (PR+) bone metastasis of breast cancer
2022 · Martin Lehr, Ahmed Dahmani, et al. · Cancer Research
Targeting progesterone receptor with the anti-progestin onaprestone in PDX models of ER+ PR+ bone metastasis of breast cancer
2022 · Lehr, Martin, Dahmani, Ahmed, et al. · HAL
Modalities of ERα36 regulation and their consequences on the pathophysiology of the mammary gland
2019 · Thiebaut, Charlène · theses.fr (ABES)
Modalités de régulation d’ERα36 et leurs conséquences sur la physiopathologie de la glande mammaire
2019 · Charlène Thiebaut
Apprentissage semi-supervisé pour la complétion de données biologiques
2018 · Boukhobza, Taha, Clausel, Marianne, et al. · HAL
Regulation of ERα36 expression: a revamped network in the old story of breast tumors
2018 · Thiébaut, Charlène, Chesnel, Amand, et al. · HAL
Validation de ER$\alpha$36 comme marqueur prédictif de susceptibilité aux nonylphénols in vivo et in vitro
2017 · Chamard-Jovenin, Clémence, Thiébaut, Charlène, et al. · HAL
ERα36 expression: a key breast cancer risk factor?
2017 · Thiébaut, Charlène, Chamard-Jovenin, Clémence, et al. · HAL
Transgenerational effects of ERalpha36 over-expression on mammary gland development and molecular phenotype: clinical perspective for breast cancer risk and therapy.
2016 · Chamard-Jovenin, Clémence, Chesnel, Amand, et al. · HAL
From ERα66 to ERα36: a new predictive marker for cancer progression and therapeutic response in breast tumors ?
2016 · Thiébaut, Charlène, Morel, Chloé, et al. · HAL
Works count: 20
Citation count: 267
H-index: 6
I10-index: 6
Year
Topic
Type